Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin

Maria Fiorella Contarino; Joost Van Den Dool; Yacov Balash; Kailash Bhatia; Nir Giladi; Johannes H Koelman; Annemette Lokkegaard; Maria J Marti; Miranda Postma; Maja Relja; Matej Skorvanek; Johannes D Speelman; Evelien Zoons; Joaquim J Ferreira; Marie Vidailhet; Alberto Albanese; Marina A J Tijssen

doi:10.3389/fneur.2017.00035

Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin

Maria Fiorella Contarino, Joost Van Den Dool, Yacov Balash, Kailash Bhatia, Nir Giladi, Johannes H Koelman, Annemette Lokkegaard, Maria J Marti, Miranda Postma, Maja Relja, Matej Skorvanek, Johannes D Speelman, Evelien Zoons, Joaquim J Ferreira, Marie Vidailhet, Alberto Albanese, Marina A J Tijssen

Institut for Klinisk Medicin

32 Citationer (Scopus)

69 Downloads (Pure)

Abstract

Cervical dystonia (CD) is the most frequent form of focal dystonia. Symptoms often result in pain and functional disability. Local injections of botulinum neurotoxin are currently the treatment of choice for CD. Although this treatment has proven effective and is widely applied worldwide, many issues still remain open in the clinical practice. We performed a systematic review of the literature on botulinum toxin treatment for CD based on a question-oriented approach, with the aim to provide practical recommendations for the treating clinicians. Key questions from the clinical practice were explored. Results suggest that while the beneficial effect of botulinum toxin treatment on different aspects of CD is well established, robust evidence is still missing concerning some practical aspects, such as dose equivalence between different formulations, optimal treatment intervals, treatment approaches, and the use of supportive techniques including electromyography or ultrasounds. Established strategies to prevent or manage common side effects (including excessive muscle weakness, pain at injection site, dysphagia) and potential contraindications to this treatment (pregnancy and lactation, use of anticoagulants, neurological comorbidities) should also be further explored.

Originalsprog	Engelsk
Artikelnummer	35
Tidsskrift	Frontiers in Neurology
Vol/bind	8
Antal sider	11
ISSN	1664-2295
DOI	https://doi.org/10.3389/fneur.2017.00035
Status	Udgivet - 24 feb. 2017

Adgang til dokumentet

10.3389/fneur.2017.00035Licens: CC BY

Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum ToxinForlagets udgivne version, 276 KBLicens: CC BY

Citationsformater

Contarino, M. F., Van Den Dool, J., Balash, Y., Bhatia, K., Giladi, N., Koelman, J. H., Lokkegaard, A., Marti, M. J., Postma, M., Relja, M., Skorvanek, M., Speelman, J. D., Zoons, E., Ferreira, J. J., Vidailhet, M., Albanese, A., & Tijssen, M. A. J. (2017). Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin. Frontiers in Neurology, 8, [35]. https://doi.org/10.3389/fneur.2017.00035

Contarino, MF, Van Den Dool, J, Balash, Y, Bhatia, K, Giladi, N, Koelman, JH, Lokkegaard, A, Marti, MJ, Postma, M, Relja, M, Skorvanek, M, Speelman, JD, Zoons, E, Ferreira, JJ, Vidailhet, M, Albanese, A & Tijssen, MAJ 2017, 'Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin', Frontiers in Neurology, bind 8, 35. https://doi.org/10.3389/fneur.2017.00035

@article{50cc625d0bf942999d59bbd776faebb5,

title = "Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin",

abstract = "Cervical dystonia (CD) is the most frequent form of focal dystonia. Symptoms often result in pain and functional disability. Local injections of botulinum neurotoxin are currently the treatment of choice for CD. Although this treatment has proven effective and is widely applied worldwide, many issues still remain open in the clinical practice. We performed a systematic review of the literature on botulinum toxin treatment for CD based on a question-oriented approach, with the aim to provide practical recommendations for the treating clinicians. Key questions from the clinical practice were explored. Results suggest that while the beneficial effect of botulinum toxin treatment on different aspects of CD is well established, robust evidence is still missing concerning some practical aspects, such as dose equivalence between different formulations, optimal treatment intervals, treatment approaches, and the use of supportive techniques including electromyography or ultrasounds. Established strategies to prevent or manage common side effects (including excessive muscle weakness, pain at injection site, dysphagia) and potential contraindications to this treatment (pregnancy and lactation, use of anticoagulants, neurological comorbidities) should also be further explored.",

keywords = "Journal Article, Review",

author = "Contarino, {Maria Fiorella} and {Van Den Dool}, Joost and Yacov Balash and Kailash Bhatia and Nir Giladi and Koelman, {Johannes H} and Annemette Lokkegaard and Marti, {Maria J} and Miranda Postma and Maja Relja and Matej Skorvanek and Speelman, {Johannes D} and Evelien Zoons and Ferreira, {Joaquim J} and Marie Vidailhet and Alberto Albanese and Tijssen, {Marina A J}",

year = "2017",

month = feb,

day = "24",

doi = "10.3389/fneur.2017.00035",

language = "English",

volume = "8",

journal = "Frontiers in Neurology",

issn = "1664-2295",

publisher = "Frontiers Research Foundation",

}

TY - JOUR

T1 - Clinical Practice

T2 - Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin

AU - Contarino, Maria Fiorella

AU - Van Den Dool, Joost

AU - Balash, Yacov

AU - Bhatia, Kailash

AU - Giladi, Nir

AU - Koelman, Johannes H

AU - Lokkegaard, Annemette

AU - Marti, Maria J

AU - Postma, Miranda

AU - Relja, Maja

AU - Skorvanek, Matej

AU - Speelman, Johannes D

AU - Zoons, Evelien

AU - Ferreira, Joaquim J

AU - Vidailhet, Marie

AU - Albanese, Alberto

AU - Tijssen, Marina A J

PY - 2017/2/24

Y1 - 2017/2/24

N2 - Cervical dystonia (CD) is the most frequent form of focal dystonia. Symptoms often result in pain and functional disability. Local injections of botulinum neurotoxin are currently the treatment of choice for CD. Although this treatment has proven effective and is widely applied worldwide, many issues still remain open in the clinical practice. We performed a systematic review of the literature on botulinum toxin treatment for CD based on a question-oriented approach, with the aim to provide practical recommendations for the treating clinicians. Key questions from the clinical practice were explored. Results suggest that while the beneficial effect of botulinum toxin treatment on different aspects of CD is well established, robust evidence is still missing concerning some practical aspects, such as dose equivalence between different formulations, optimal treatment intervals, treatment approaches, and the use of supportive techniques including electromyography or ultrasounds. Established strategies to prevent or manage common side effects (including excessive muscle weakness, pain at injection site, dysphagia) and potential contraindications to this treatment (pregnancy and lactation, use of anticoagulants, neurological comorbidities) should also be further explored.

AB - Cervical dystonia (CD) is the most frequent form of focal dystonia. Symptoms often result in pain and functional disability. Local injections of botulinum neurotoxin are currently the treatment of choice for CD. Although this treatment has proven effective and is widely applied worldwide, many issues still remain open in the clinical practice. We performed a systematic review of the literature on botulinum toxin treatment for CD based on a question-oriented approach, with the aim to provide practical recommendations for the treating clinicians. Key questions from the clinical practice were explored. Results suggest that while the beneficial effect of botulinum toxin treatment on different aspects of CD is well established, robust evidence is still missing concerning some practical aspects, such as dose equivalence between different formulations, optimal treatment intervals, treatment approaches, and the use of supportive techniques including electromyography or ultrasounds. Established strategies to prevent or manage common side effects (including excessive muscle weakness, pain at injection site, dysphagia) and potential contraindications to this treatment (pregnancy and lactation, use of anticoagulants, neurological comorbidities) should also be further explored.

KW - Journal Article

KW - Review

U2 - 10.3389/fneur.2017.00035

DO - 10.3389/fneur.2017.00035

M3 - Review

C2 - 28286494

SN - 1664-2295

VL - 8

JO - Frontiers in Neurology

JF - Frontiers in Neurology

M1 - 35

ER -

Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater